Data Published in the "International Journal of Urology" Also Showed Secondary Endpoints, Such as Onset of action in 15 Minutes and Percentage of Patients Reaching Normal Erectile Function According to the
Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(0.09) per share. This is a 59.09 percent increase over losses of $(0.22) per share from the same period last year. The company reported $4.20 million